483
Genentech, Inc.Genentech, Inc. – FDA 483, Aug 11, 2023
Record Details
An FDA inspection of Genentech, Inc. in South San Francisco, CA, identified one observation related to their role as a sponsor of a clinical study. The firm failed to notify the FDA about the termination, for cause, of a principal investigator's participation in an investigation. This indicates a lapse in regulatory reporting requirements for clinical trials.
View Company Profile
ID · ce85e9f0-3331-495a-b1b4-a7e2df5fa79b
Other documents for Genentech, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.